Chung I Choi, CVrg’s ASCVD lead, will be on the ground in New Orleans covering key sessions at AHA 2025.

CVrg Conference Details: cv-rg.com/conferences/

#AHA2025 #ASCVD #ClinicalResearch #cardiovascular #CompetitiveStrategy #CVrg #BPrg

CVrg’s Matt Racine, Ph.D. will be onsite at the HCMS + AHA Scientific Sessions in New Orleans for deeper dives into MAPLE-HCM, ODYSSEY-HCM, and a host of earlier-stage product updates.
AHA Conferece Coverage details: cv-rg.com/conferences/...
#AHA2025 #HeartFailure #ClinicalData #CVrg

🚨CVrg is heading to the ASN Annual Meeting
As part of our comprehensive CKD coverage, we’ll be covering the latest in Diabetic Kidney Disease, ESRD, AKI, and rare glomerular diseases.
#ASN2025 #KidneyWeek #ClinicalTrials #CKD #KidneyDisease #ESRD #CompetitiveInsights #CVrg #BPrg

CVrg is attending ObesityWeek® 2025 tracking cutting‑edge data on next‑generation obesity therapies, including GLP‑1s, GLP‑1 combinations, amylins, and emerging novel agents, and their impact on obesity and its associated comorbidities.
#obesityweek #GLP1 #MarketInsights

CVrg has released our latest CKD Insights report, with the spotlight on IgA Nephropathy (IgAN)—one of the most rapidly evolving areas in chronic kidney disease.
Want to see the full picture?
Request a sample: cv-rg.com/marketinsigh...
#CKD #IgAN #ASN2025 #kidneydiseases

CVrg is excited to attend Pharma CI USA, Sept 17–18 in NJ! If you’re attending, we’d love the opportunity to meet and share more about CVrg’s offerings and how we support strategic decision-making.
#PharmaCI2025 #Biotech #CompetitiveIntelligence #CompetitiveStrategy #CVrg

Our CVrg team will be on the ground at EASD 2025 analyzing the latest data in diabetes, obesity, and the risk factors associated with metabolic diseases.

CVrg's EASD 2025 Coverage: cv-rg.com/conferences/...

#EASD2025 #Cardiovascular #Metabolic #Obesity #Diabetes #CompetitiveStrategy

🚨 Countdown to #ESC2025: August 29!
CVrg's ASCVD lead, Chung I Choi, will be paying close attention to the hot areas of Lp(a) and inflammation in anticipation of Phase III trial readouts next year.

#ESC2025 #Cardiovascular #Metabolic #ASCVD #CompetitiveStrategy #MedicalIntelligence #CVrg

🚨 Countdown to #ESC2025: August 29!
The Hot Line 2 session is already shaping up to be one of the most anticipated.

👉 We’d value your perspective—Take our CVrg ESC Poll www.linkedin.com/feed/update/...

#ESC2025 #Cardiovascular #Metabolic #CompetitiveStrategy #MedicalIntelligence #CVrg